Explore the Sept-Oct 2026 edition
For years, the infection prevention community has wrestled with problematic manufacturers’ instructions for use (MIFU) that complicate the cleaning, disinfection and even sterilization of medical devices, instruments and equipment. The Food and Drug Administration (FDA) began regulating device labeling in a formal sense in 1976, but it began directly and systematically addressing problematic or confusing MIFUs through human-factors work around the late 1990s and early 2000s, particularly with guidance issued in 2000 and 2001. The FDA increasingly addressed whether device users could understand and safely follow labeling through human-factors and usability engineering. This reflected recognition that unclear instructions could contribute to errors and patient harm.
+ Highlights from AHE Exchange 26
Access the Sept-Oct 2026 edition
Explore the July-Aug 2026 edition
In this edition, Healthcare Hygiene magazine reports on the most important issues emerging from the annual APIC meeting.
+ Strengthening Infection Control: Risks, Gaps, and Opportunities
In the session, “Strengthening Infection Control: Risks, Gaps, and Opportunities,” panelists comprised of infection prevention and control experts and surveyors shared their insights by exploring the most significant IPC-related risks and compliance challenges observed across healthcare organizations and care settings. Panelists discuss common gaps in Infection Control programs, discuss frequently overlooked foundational practices, and identify opportunities to strengthen regulatory compliance and patient safety outcomes.
+ Advancing Infection Prevention Guidance: Updates from APIC Practice Guidance Committee
In the session, “Advancing Infection Prevention Guidance: Updates from APIC Practice Guidance Committee,” presenters explained how APIC’s PGC compiles, assesses, develops, and influences guidelines and standards related to infection prevention and control (IPC). The PGC provides a means within APIC to guide and inform the membership on practice issues and recommends official positions on standard guidelines and other pertinent documents affecting IPC practice.
Access the July-Aug 2026 edition
Explore the May-June 2026 edition
In this edition, Healthcare Hygiene magazine shares insights from experts on how to empower IPs to connect and collaborate with healthcare leaders.
Despite the mutual benefits inherent to regularly occurring executive/IP interaction, some IPs may hesitate to communicate with the hospital C-suite due to a lack of established communication pathways and potential barriers such as differing priorities or misunderstandings about their role. Additionally, they often need to influence change without direct authority, which can create challenges in effectively conveying their concerns and recommendations.
Access the May-June 2026 Edition
Explore the March-April 2026 Edition
Pushing past the double doors leading to the operating suite or the sterile processing department can feel like passing the point of no return to an infection preventionist who is either a novice or comes from a non-clinical background, or both. Even some veteran IPs may feel some degree of trepidation at the prospect of observing in areas of the hospital that may seem complex and mysterious.
Access the march-april 2026 edition
Explore the Jan-Feb 2026 Edition
In the December 2025 SHEA Town Hall, “Cracking C. Diff: Evidence-based Approaches & Real-World Impact,” panelists tackled the hard questions related to addressing one of healthcare’s most formidable foes.
Access the Jan-Feb 2026 Edition
HHM archives